Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer

Author： Kong Sun-Young   Lim Hyeong-Seok   Nam Byung-Ho   Kook Myeong-Cherl   Kim Young-Woo   Won Ryu Keun   Lee Jun Ho   Choi Il Ju   Lee Jin Soo   Park Young-Iee   Kim Noe Kyeong   Park Sook Ryun  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.10, Iss.7, 2009-07, pp. : 1147-1155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

By Boku Narikazu   Muro Kei   Machida Nozomu   Hashigaki Satoshi   Kimura Nobuyuki   Suzuki Mie   Lechuga Mariajose   Miyata Yoshinori  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel plus cisplatin: active and well tolerated in locally advanced or metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Trastuzumab plus docetaxel in metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. : 43-53

Bentham Science Publishers

Access to resources Recommend Favorite

Concurrent treatment with epirubicin, docetaxel and cisplatin shows activity in metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite